In diseased livers, GPR84 gene expression was associated with the inflammation grading of the NAFLD Activity Score (NAS), as well as with the fibrosis stage, but not with steatosis (Figure 1A). Here, GPR84 is linked to metabolic dysfunction-associated steatotic liver disease.